Source comparison
Study Design: Acute vs Chronic Dosing Protocols
Animal studies prioritize mechanistic clarity under controlled conditions. A typical rodent protocol administers MK-677 as a single bolus dose or short-term regimen (3–14 days), measures acute outcomes (GH secretion, muscle protein synthesis markers, tissue IG
This comparison does not assign a generated winner or score.
- Animal studies prioritize mechanistic clarity under controlled conditions. A typical rodent protocol administers MK-677 as a single bolus dose or short-term regimen (3–14 days), measures acute outcomes (GH secretion, muscle protein synthesis markers, tissue IGF-1 expression), and uses doses scaled far higher than human equivalents to produce measurable effects in small-bodied subjects. Example: a 2017 study from Seoul National University administered 10mg/kg MK-677 to aged rats for 28 days and found significant increases in tibial bone mineral density and femoral strength. Outcomes measured in controlled lab environments with no dietary variance, no comorbidities, and genetically identical subjects.
- Human trials, by contrast, use chronic daily dosing over months, assess body composition via DEXA scan, measure fasting glucose and insulin sensitivity to track metabolic side effects, and enroll heterogeneous populations (varying age, BMI, baseline IGF-1 levels). The longest published human trial ran for two years in elderly subjects, revealing that MK-677's GH-elevating effects persist without tachyphylaxis but are accompanied by mild insulin resistance and increased fasting glucose in a subset of participants. An effect not captured in short-term rodent models.
- Dose equivalence is another gap. A 10mg/kg dose in a 250g rat equals 2.5mg absolute dose. Scaled allometrically to a 70kg human using body surface area (the FDA-recommended conversion method), that translates to approximately 20mg. But rodent studies often use 25–50mg/kg to achieve robust effects, which would scale to 125–250mg in humans, far exceeding clinical doses. Real Peptides maintains strict dosing protocols calibrated to human-equivalent ranges, ensuring research-grade peptides are prepared at concentrations suitable for translational work without overestimating potency based on preclinical models.